EBQ:LRINEC Score: Difference between revisions
Mceledon83 (talk | contribs) |
Ostermayer (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
| fulltexturl= http://ovidsp.tx.ovid.com.journals.labiomed.org/sp-3.12.0b/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&AN=00003246-200407000-00011&NEWS=N&CSC=Y&CHANNEL=PubMed | | fulltexturl= http://ovidsp.tx.ovid.com.journals.labiomed.org/sp-3.12.0b/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&AN=00003246-200407000-00011&NEWS=N&CSC=Y&CHANNEL=PubMed | ||
| pdfurl=http://theddx.org/papers/LRINEC.pdf | | pdfurl=http://theddx.org/papers/LRINEC.pdf | ||
| status="Under Review" | |||
}} | }} | ||
==Clinical Question== | ==Clinical Question== | ||
Revision as of 20:34, 18 October 2014
"Under Review" Journal Club Article
Wong C. "The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections". Crit Care Med. 2004. 32(7):1535-41.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
- Is it possible to develop a diagnostic scoring system to distinguish necrotizing fasciitis (NF) from other soft tissue infections based on laboratory tests routinely performed for the evaluation of severe soft tissue infections?
- Developed the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score to aid in the to risk stratification of patients presenting with signs of cellulitis in order determine likelihoood of NF.
Conclusion
Major Points
Study Design
Population
Patient Demographics
Inclusion Criteria
Exclusion Criteria
Interventions
Outcomes
Primary Outcome
Secondary Outcomes
Subgroup analysis
Criticisms & Further Discussion
Funding
Sources
[{Category:Derm]]